Hiroshi Shiku
#139,064
Most Influential Person Now
Researcher
Hiroshi Shiku's AcademicInfluence.com Rankings
Hiroshi Shikuengineering Degrees
Engineering
#5114
World Rank
#6357
Historical Rank
Cybernetics
#83
World Rank
#89
Historical Rank
Biomedical Engineering
#362
World Rank
#371
Historical Rank

Download Badge
Engineering
Hiroshi Shiku's Degrees
- PhD Biomedical Engineering University of Tokyo
- Masters Biomedical Engineering Kyoto University
- Bachelors Biomedical Engineering Kyoto University
Why Is Hiroshi Shiku Influential?
(Suggest an Edit or Addition)Hiroshi Shiku's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Eradication of established tumors by CD8+ T cell adoptive immunotherapy. (2000) (373)
- Engineering hybrid exosomes by membrane fusion with liposomes (2016) (370)
- Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. (1996) (362)
- Classification of current anticancer immunotherapies (2014) (357)
- De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. (2002) (300)
- Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens (1976) (218)
- Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. (1979) (212)
- RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses. (2008) (208)
- Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma (1977) (207)
- Expression of T-cell differentiation antigens on effector cells in cell- mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells (1975) (202)
- Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. (2009) (187)
- Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. (1994) (185)
- Serological analysis of cell surface antigens of malignant human brain tumors. (1978) (184)
- Notch signalling in hematopoiesis. (2003) (181)
- CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses (2003) (178)
- Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse (1975) (176)
- Outcome of Disseminated Intravascular Coagulation in Relation to the Score when Treatment was Begun (1995) (169)
- In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. (2006) (168)
- Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. (1997) (168)
- Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer (2002) (167)
- Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. (1995) (167)
- Cell surface antigens of human renal cancer defined by autologous typing (1979) (157)
- Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. (2007) (157)
- Defining the critical hurdles in cancer immunotherapy (2011) (152)
- Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC (2003) (145)
- Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. (1992) (143)
- mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies (2004) (141)
- Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF‐cleaving protease activity (2002) (138)
- Tissue Factor Expression and Metastatic Potential of Colorectal Cancer (1998) (134)
- Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells (2005) (134)
- Human melanoma antigen AH is an autoantigenic ganglioside related to GD2 (1982) (132)
- Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer (2015) (130)
- Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals (2010) (128)
- Reduced expression of nm23‐H1, but not of nm23‐H2, is concordant with the frequency of lymph‐node metastasis of human breast cancer (1993) (127)
- Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel (2008) (123)
- Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. (2005) (123)
- Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. (1993) (122)
- T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. (2007) (122)
- Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. (2011) (121)
- De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients (2008) (120)
- CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. (2008) (119)
- [DNA vaccine]. (2008) (118)
- Distinguishing Pancreatic Carcinoma From Other Periampullary Carcinomas by Analysis of Mutations in the Kirsten‐ras Oncogene (1991) (117)
- Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics (1977) (116)
- Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells (2018) (115)
- Frequent Glycine‐to‐Aspartic Acid Mutations at Codon 12 of c‐Ki‐ras Gene in Human Pancreatic Cancer in Japanese (1990) (112)
- Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS. (2017) (110)
- Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma. (1997) (109)
- Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase. (1999) (109)
- A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. (1998) (106)
- Complex gangliosides are essential in spermatogenesis of mice: Possible roles in the transport of testosterone (1998) (105)
- HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan (2006) (105)
- Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity. (2014) (105)
- Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. (1996) (104)
- IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response1 (2005) (98)
- Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. (1995) (97)
- Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy. (2002) (96)
- Exosome‐mediated regulation of tumor immunology (2018) (90)
- De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. (1998) (90)
- Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients (2013) (87)
- Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells (2000) (85)
- Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. (2001) (85)
- Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. (1993) (84)
- Increased plasma‐soluble fibrin monomer levels in patients with disseminated intravascular coagulation (1996) (82)
- Expression of human nm23‐H1 and nm23‐H2 proteins in hepatocellular carcinoma (1994) (81)
- De novo CD5‐positive diffuse large B‐cell lymphoma: clinical characteristics and therapeutic outcome (1999) (80)
- Hematopoietic origin of hepatic stellate cells in the adult liver. (2008) (80)
- Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. (2008) (77)
- Survival of human leukaemic B‐cell precursors is supported by stromal cells and cytokines: association with the expression of bcl‐2 protein (1999) (77)
- Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance (2019) (75)
- Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity (2001) (75)
- Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion. (2001) (74)
- Ly phenotype of cytotoxic T cells for syngeneic tumor (1976) (73)
- Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses (2015) (73)
- Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents (1998) (73)
- Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases (2000) (72)
- Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma (1993) (70)
- A novel role for Notch ligand Delta‐1 as a regulator of human Langerhans cell development from blood monocytes (2005) (70)
- A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity (1995) (70)
- Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. (1991) (69)
- Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries (1998) (67)
- Heterogeneity in the Expression Pattern of Two Ganglioside Synthase Genes During Mouse Brain Development (1996) (65)
- Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas. (2003) (65)
- Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients (2007) (65)
- Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units. (1996) (64)
- Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation (1996) (64)
- Molecular cloning and functional expression of the second mouse nm23/NDP kinase gene, nm23‐M2 (1992) (64)
- Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo. (1997) (64)
- Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML (2003) (63)
- The effects of the site-directed removal of N-glycosylation sites from beta-1,4-N-acetylgalactosaminyltransferase on its function. (1995) (62)
- Importance of CD80/CD86–CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells (2008) (62)
- siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions (2011) (62)
- Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity. (1979) (62)
- Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon gamma in listerial infection (1990) (62)
- Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation. (1997) (61)
- Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination. (2018) (61)
- Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment (1998) (60)
- Hemostatic molecular markers before the onset of disseminated intravascular coagulation (1999) (59)
- Increased tissue factor pathway inhibitor in patients with acute myocardial infarction (1997) (59)
- Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. (1980) (59)
- GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax. (1993) (57)
- Treatment outcome of nasal NK‑cell lymphoma: A report of 12 consecutively‑diagnosed cases and a review of the literature (2001) (57)
- Expression profiling analysis of the CD5+ diffuse large B‐cell lymphoma subgroup: Development of a CD5 signature (2006) (57)
- Expression of CD44 Variant Exons 8–10 in Colorectal Cancer and Its Relationship to Metastasis (1995) (56)
- Reprogramming of human postmitotic neutrophils into macrophages by growth factors. (2004) (56)
- High plasma fibrinogen level is associated with poor clinical outcome in DIC patients (2003) (56)
- Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. (2009) (54)
- Expression of nm23/NDP kinase proteins on the cell surface. (1993) (54)
- Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele. (2012) (53)
- Expression of DCC Protein in Colorectal Tumors and Its Relationship to Tumor Progression and Metastasis (1999) (53)
- Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. (1993) (53)
- Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention. (2000) (53)
- Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. (1988) (53)
- Cell‐mediated cytotoxicity for cultured autologous melanoma cells (1979) (53)
- Attenuation of Interleukin 2 Signal in the Spleen Cells of Complex Ganglioside-lacking Mice* (1999) (51)
- Bax Induction Activates Apoptotic Cascade via Mitochondrial Cytochrome c Release and Bax Overexpression Enhances Apoptosis Induced by Chemotherapeutic Agents in DLD‐1 Colon Cancer Cells (2000) (50)
- IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. (2005) (50)
- Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response (2011) (50)
- Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. (1990) (50)
- Features of early gastric cancer and gastric adenoma by enhanced-magnification endoscopy (2006) (49)
- CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity (2016) (49)
- Importance of CD4+ Helper T-cells in Antitumor Immunity (2003) (48)
- Substrate Specificity of 1,4-N-Acetylgalactosaminyltransferase in Vitro and in cDNA-transfected Cells (1995) (48)
- Activated t‐lymphocytes with polyclonal gammopathy in patients with human t‐lymphotropic virus type i—associated myelopathy (1988) (48)
- Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE (2005) (48)
- Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination (2008) (48)
- Glucocorticoid‐induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen‐specific CD8+ T cells with tumor regression (2009) (48)
- Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia (2002) (48)
- High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine. (2014) (47)
- Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. (2002) (47)
- Decreased Plasma Tissue Factor Pathway Inhibitor Levels in Patients with Thrombotic Thrombocytopenic Purpura (1995) (47)
- Tissue factor expression in endothelial cells in health and disease (1995) (47)
- Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. (1998) (47)
- Detection of the c‐myc Gene Product in Urinary Bladder Cancer (1990) (46)
- Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology (2009) (46)
- Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis (2001) (46)
- Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. (1995) (46)
- Point Mutations of c‐ras Genes in Human Bladder Cancer and Kidney Cancer (1990) (46)
- Exosomal regulation of lymphocyte homing to the gut. (2018) (46)
- Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor‐specific CD8+ T cells (2009) (45)
- Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta. (1996) (45)
- Development of a cancer vaccine: peptides, proteins, and DNA (2000) (45)
- Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. (2012) (45)
- Expression of α2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes (1995) (45)
- Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation (2006) (45)
- Interleukin-17 Induces an Atypical M2-Like Macrophage Subpopulation That Regulates Intestinal Inflammation (2014) (44)
- Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021. (1996) (44)
- Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells (2010) (44)
- Production and characterization of monoclonal antibody against 10S DNA polymerase a from calf thymus (1982) (43)
- Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432. (2009) (43)
- In vitro Stimulation of CD8 and CD4 T Cells by Dendritic Cells Loaded with a Complex of Cholesterol-Bearing Hydrophobized Pullulan and NY-ESO-1 Protein: Identification of a New HLA-DR15–Binding CD4 T-Cell Epitope (2006) (43)
- The Soluble Notch Ligand, Jagged-1, Inhibits Proliferation of CD34+ Macrophage Progenitors (2002) (43)
- A novel human HER2‐derived peptide homologous to the mouse Kd‐restricted tumor rejection antigen can induce HLA‐A24‐restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals (2000) (41)
- A HER2/NEU‐derived peptide, a Kd‐restricted murine tumor rejection antigen, induces HER2‐specific HLA‐A2402‐restricted CD8+ cytotoxic T lymphocytes (2000) (41)
- Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. (2013) (41)
- Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. (1991) (41)
- Relationship between the anti‐HTLV‐1 antibody level, the number of abnormal lymphocytes and the viral‐genome dose in HTLV‐1‐infected individuals (1993) (40)
- IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. (2009) (40)
- Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient (2008) (40)
- erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. (1994) (40)
- Differential Regulatory Function of Resting and Preactivated Allergen-Specific CD4+CD25+ Regulatory T Cells in Th2-Type Airway Inflammation1 (2008) (40)
- Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor (2013) (39)
- Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. (1989) (39)
- Alternatively spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome (1991) (38)
- Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. (1999) (38)
- Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes. (1995) (38)
- Expression of c-myc gene product in gastric carcinoma. (1991) (38)
- Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome (2016) (38)
- Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells. (1995) (37)
- The Blood Group P1 Synthase Gene Is Identical to the Gb3/CD77 Synthase Gene (2003) (36)
- Expression of c‐myc Oncogens Product and ras Family Oncogene Products in Various Human Malignant Lymphomas Defined by Immunohistochemical Techniques (1988) (36)
- Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation (1996) (35)
- Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation (1997) (35)
- Expression of CD44 Variant Exons 8‐10 in Gastric Cancer (1995) (34)
- Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes (2009) (34)
- gamma delta T-cell lymphoma: a clinicopathologic study of 6 cases including extrahepatosplenic type. (1999) (34)
- Plasma Levels of Total Plasminogen Activator Inhibitor-I (PAI-I) and tPA/PAI-1 Complex in Patients With Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura (2001) (34)
- Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature. (2004) (34)
- Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor α-chain predicts a poor prognosis (2007) (34)
- Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis (1995) (33)
- Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin (1998) (33)
- CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection (1991) (33)
- IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. (1991) (33)
- Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector. (2008) (33)
- Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C (1995) (32)
- Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. (1992) (32)
- Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation (2010) (31)
- Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses (2011) (31)
- A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression (2012) (30)
- Haemostatic abnormalities and thrombotic disorders in malignant lymphoma (2004) (30)
- Cyclin D1 Expression Is Useful as a Prognostic Indicator for Advanced Esophageal Carcinomas, but Not for Superficial Tumors (2000) (30)
- Increased Soluble Fibrin in Plasma of Patients with Disseminated Intravascular Coagulation (2003) (30)
- Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease (1999) (30)
- Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. (1998) (30)
- Post-immune UV irradiation induces Tr1-like regulatory T cells that suppress humoral immune responses. (2008) (29)
- Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. (2006) (29)
- Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy (2014) (29)
- Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms. (1996) (29)
- Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines. (1994) (29)
- Expression of ras p21 in mammary and extramammary Paget's disease. (1990) (29)
- Bax overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis. (2000) (29)
- Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells (1982) (29)
- Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma. (2019) (28)
- THE ROLE OF CD8+ AND CD4+ CELLS IN ISLET ALLOGRAFT REJECTION (1990) (28)
- Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation (1998) (28)
- Increased Plasma Thrombomodulin as a Vascular Endothelial Cell Marker in Patients With Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome (2001) (28)
- Translocation of protein phosphatase 1 catalytic subunits during 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL-60 cells. (1995) (28)
- Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction (1995) (28)
- Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma. (2006) (27)
- Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid. (1995) (27)
- Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. (2000) (27)
- Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice. (1993) (27)
- Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis (2006) (26)
- Efficient ex vivo generation of dendritic cells from CD14+ blood monocytes in the presence of human serum albumin for use in clinical vaccine trials (2001) (26)
- Plasma levels of activated protein C–protein C inhibitor complex in patients with hypercoagulable states (2000) (26)
- Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity. (2012) (26)
- Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature. (2006) (26)
- Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression (2015) (26)
- Differential Association of Protein Ser/Thr Phosphatase Types 1 and 2A with the Cytoskeleton upon Platelet Activation (1996) (26)
- Activities of granulocyte‐macrophage colony‐stimulating factor and interleukin‐3 on monocytes (2004) (26)
- Established IL‐2‐dependent double‐negative (CD4‐ CD8‐) TCRαβ/CD3+ ATL cells: induction of CD4 expression (1994) (26)
- Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer. (2014) (26)
- T‐cell receptor gene therapy targeting melanoma‐associated antigen‐A4 inhibits human tumor growth in non‐obese diabetic/SCID/γcnull mice (2012) (25)
- Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies. (2005) (25)
- Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori. (2001) (25)
- Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. (1994) (25)
- Involvement of T‐cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin‐12 (IL‐12) genes (1997) (25)
- Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases (2004) (24)
- HER2 peptide-specific CD8+ T cells are proportionally detectable long after multiple DNA vaccinations (2002) (24)
- Histopathological Study of the Role of CD4- and CD8-Positive T Cells on Bone Resorption Induced by Escherichia coli Endotoxin (1998) (24)
- Possible involvement of bcl‐2 in regulation of cell‐cycle progression of haemopoietic cells by transforming growth factor‐β1 (1999) (24)
- Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation (1999) (24)
- Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells. (2006) (24)
- The Membrane Proteinase 3 Expression on Neutrophils Was Downregulated After Treatment With Infliximab in Patients With Rheumatoid Arthritis (2008) (23)
- Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis (2000) (23)
- Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells (2019) (23)
- Aberrations of the Tissue Factor Pathway in Patients Positive for Lupus Anticoagulant (1999) (23)
- Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism. (2005) (23)
- Electrochemical/photochemical formation of enzyme patterns on glass substrates using a scanning electrochemical/confocal microscope (2003) (23)
- Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC. (2001) (23)
- Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype. (2000) (23)
- Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test. (1975) (23)
- Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. (1994) (23)
- Expression of alpha 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. (1995) (23)
- PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma. (1996) (22)
- The Roles of CD8+ and CD4+ Cells in Tumor Rejection (1989) (22)
- Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha). (2003) (22)
- Usefulness of Fully Automated Measurement of Reticulated Platelets Using Whole Blood (2005) (21)
- Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel (2016) (21)
- Adult T cell leukaemia cells are of CD4+ CDw29+ T cell origin and secrete a B cell differentiation factor (1989) (21)
- First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer (2019) (21)
- UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses (2011) (21)
- Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V. (2000) (21)
- A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy. (2013) (21)
- De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumor. (2006) (20)
- Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura (2005) (20)
- Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen (1991) (20)
- Analysis of cell surface molecules on human platelets with monoclonal antibodies. I. Identification of four platelet-specific surface molecules. (1986) (20)
- MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours (2020) (20)
- Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) αβ genes transduced to CD8+ T cells (2008) (20)
- Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases (2003) (19)
- Ileocolonic lymphomas: a series of 16 cases. (2005) (19)
- Hemostatic Abnormalities and Changes Following Bone Marrow Transplantation (2004) (19)
- Granulocyte colony‐stimulating factor and its receptor in acute promyelocytic leukemia (1998) (19)
- Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis. (2005) (18)
- T cell receptor‐mediated stimulation of mouse thymocytes induces up‐regulation of the GM2/GD2 synthase gene (1995) (18)
- Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin‐2 receptor α chain (1999) (18)
- Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia (2016) (18)
- Long-term survival of orthotopic Lewis liver grafts in Wistar Furth rats. Elimination or inactivation of effector CTL and altered antigenicity as possible reasons for tolerance. (1994) (18)
- Human Cancer Immunology (1980) (18)
- Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. (1997) (18)
- First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors (2020) (18)
- Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. (2001) (18)
- Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. (2001) (18)
- Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types (2016) (17)
- Expressions of four major protein Ser/Thr phosphatases in human primary leukemic cells (1999) (17)
- Elevated Plasma Levels of Fibrin Degradation Productsby Granulocyte-Derived Elastase in Patients with Disseminated Intravascular Coagulation (2005) (17)
- Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality (1999) (17)
- Kobayashi T, Ruan SB, Clodi K, Kliche KO, Shiku H, Andreeff M and Zhang WOverexpression of bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene 16: 1587-1591 (1998) (17)
- State-of-the-Art Review : Increased Activated Protein C: Protein C Inhibitor Complex and Decreased Protein C Inhibitor Levels in Patients with Chronic Renal Failure on Maintenance Hemodialysis (1999) (17)
- Independent and differential expression of two isotypes of human Nm23: analysis of the promoter regions of the nm23-H1 and H2 genes. (1996) (17)
- Plasma concentration of itraconazole and its antifungal prophylactic efficacy in patients with neutropenia after chemotherapy for acute leukemia (1999) (16)
- Relationship between development of nephrotoxicity and blood concentration of cyclosporine A in bone-marrow transplanted recipients who received the continuous intravenous infusion. (2003) (16)
- UV irradiation after immunization induces type 1 regulatory T cells that suppress Th2-type immune responses via secretion of IL-10. (2010) (16)
- Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura. (2007) (16)
- Substrate specificity of beta 1,4-N-acetylgalactosaminyltransferase in vitro and in cDNA-transfected cells. GM2/GD2 synthase efficiently generates asialo-GM2 in certain cells. (1995) (16)
- Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients (2021) (16)
- Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination. (1988) (16)
- Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM. (1991) (16)
- Case of chronic‐phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin (2004) (16)
- Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells. (2006) (15)
- Bone marrow-derived dendritic cells incorporate and process hydrophobized polysaccharide/oncoprotein complex as antigen presenting cells. (1999) (15)
- Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients. (2007) (15)
- HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia. (1999) (15)
- Induction of in vitro and in vivo anti‐tumor responses by sensitization of mice with liposomes containing a crude butanol extract of leukemia cells and transferred inter‐membranously with cell‐surface proteins (1991) (15)
- CD21S antigen expression in tumour cells of diffuse large B‐cell lymphomas is an independent prognostic factor indicating better overall survival (2004) (15)
- Notch ligand Delta‐1 differentially modulates the effects of gp130 activation on interleukin‐6 receptor α‐positive and ‐negative human hematopoietic progenitors (2007) (15)
- PROTEINASE 3 EXPRESSION ON NEUTROPHIL MEMBRANES FROM PATIENTS WITH INFECTIOUS DISEASE (2006) (15)
- Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. (1996) (15)
- Genetic remodeling of gangliosides resulted in the enhanced reactions to the foreign substances in skin. (1997) (15)
- 1 alpha,25-dihydroxyvitamin D3-induced upregulation of calcineurin during leukemic HL-60 cell differentiation. (1996) (15)
- Reduced Cd 4 + Cd 25 + T cells in patients with idiopathic thrombocytopenic purpura (2006) (14)
- Up‐regulation of protein serine/threonine phosphatase type 2C during 1α,25‐dihydroxyvitamin D3‐induced monocytic differentiation of leukemic HL‐60 cells (1995) (14)
- Antileukemia multifunctionality of CD4+ T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer (2015) (14)
- Genomic Organization and Chromosomal Assignment of the Human β1,4-N-Acetylgalactosaminyltransferase Gene (1996) (14)
- CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor (2020) (14)
- Expression of hepatocyte growth factor(hgf) and C-met gene in human gastric-cancer cell-lines. (1993) (14)
- Decreased tissue factor and tissue‐plasminogen activator antigen in relapsed acute promyelocytic leukemia (2000) (14)
- Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation (1999) (14)
- IL-3 can not replace GM-CSF in inducing human monocytes to differentiate into Langerhans cells. (2007) (14)
- Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies. (1988) (14)
- Human nm23-h1-protein and h2-protein have similar nucleoside diphosphate kinase-activities. (1992) (14)
- Tumor-specific Crosslinking of GITR as Costimulation for Immunotherapy (2010) (14)
- Antibody-dependent cell-mediated cytotoxicity for cultured autologous melanoma cells. (1981) (13)
- Distinguishing functional exosomes and other extracellular vesicles as a nucleic acid cargo by the anion‐exchange method (2022) (13)
- Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis (2012) (13)
- Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. (1998) (13)
- Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications. (2021) (13)
- Rho-kinase induces association of adducin with the cytoskeleton in platelet activation. (2005) (13)
- Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti‐tumor responses (1990) (13)
- Gastric mucosa-associated lymphoid tissue lymphoma with a focal high-grade component diagnosed by EUS and endoscopic mucosal resection for histologic evaluation. (2000) (13)
- A putative role for histone deacetylase in the differentiation of human erythroid cells. (2005) (12)
- Development of a unique T-cell receptor gene-transferred Tax-redirected T-cell immunotherapy for adult T-cell leukemia. (2020) (12)
- Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity (2016) (12)
- Successful treatment with low‐dose splenic irradiation for massive splenomegaly in an elderly patient with hairy‐cell leukemia (2001) (12)
- Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation. (2003) (12)
- Overcoming regulatory T‐cell suppression by a lyophilized preparation of Streptococcus pyogenes (2013) (12)
- Expression of Kirsten‐ras p21 in Gastric Cancer Correlates with Tumor Progression and Is Prognostic (1994) (12)
- Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells. (1993) (12)
- Mapping peroxidase in plant tissues by scanning electrochemical microscopy. (2001) (12)
- Treatment of radiation-induced hemorrhagic duodenitis with argon plasma coagulation. (2004) (12)
- State-of-the-Art Review : Elevated Tissue Factor Levels in Leukemic Cell Homogenate (2000) (12)
- Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens (1986) (12)
- Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression. (2006) (12)
- Development of Mixed-Type Autoimmune Hemolytic Anemia and Evans’ Syndrome following Chicken Pox Infection in a Case of Low-Titer Cold Agglutinin Disease (2006) (12)
- Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens. (1989) (11)
- Preferential usage of JH2 in D‐J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequences (1992) (11)
- Comparison of multiple rosetting assays for detecting antibody reactivity of different immunoglobulin classes against surface antigens of benign and malignant tissue culture cells. (1980) (11)
- Acute promyelocytic leukemia with del(6)(p23). (2000) (11)
- Clinical relevance of antigen spreading pattern induced by CHP-MAGE-A4 cancer vaccination. (2016) (11)
- Correlation of p53 expression and proliferative activity in gastric cancer. (1993) (11)
- Analysis of cell surface molecules on human platelets with monoclonal antibodies. II. Diversity of antibody-binding sites on molecules and its relation to platelet function. (1986) (11)
- Increased Expression of ras Genes in Non‐Hodgkin's Lymphomas Is not Associated with Oncogenic Activation of Those Genes by Point Mutation (1989) (11)
- A new differentiation antigen defining a subpopulation of mouse T cells (1976) (11)
- K‐ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters (1997) (11)
- Decreased expression of protein phosphatase type 2A in HL-60 variant (HL-60RAr) cells resistant to induction of cell differentiation by all-trans retinoic acid. (1995) (11)
- Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients (2005) (10)
- NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma (2018) (10)
- Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring. (1999) (10)
- Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model. (2013) (10)
- Plasma levels of activated FVII in various diseases. (1996) (10)
- Systemic CD8+ T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor (2014) (10)
- Clinicopathologic Significance of Loss of CD19 Expression in Diffuse Large B-Cell Lymphoma (2007) (10)
- Diverse Expression of β1,4‐N‐Acetylgalactosaminyltransferase Gene in the Adult Mouse Brain (1995) (10)
- Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation. (2002) (10)
- Analysis of Clonal Relationship Using Single-Cell Polymerase Chain Reaction in a Patient with Concomitant Mantle Cell Lymphoma and Multiple Myeloma (2001) (10)
- Acute interstitial pneumonitis during chemotherapy for haematological malignancy. (2005) (9)
- Two Independent Clones in Myelodysplastic Syndrome Following Treatment of Acute Myeloid Leukemia (2002) (9)
- CD44 with variant exons 8-10 in colorectal tumors. (1996) (9)
- Alteration of tumor phenotypes of B16 melanoma after genetic remodeling of the ganglioside profile. (2000) (9)
- Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy. (2006) (9)
- Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation. (2005) (9)
- Gene expression profiling of diffuse large B‐cell lymphoma supervised by CD21 expression (2008) (9)
- Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation (2003) (9)
- NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome (2022) (9)
- Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO. (2005) (9)
- V(D)J recombinase activity in primary and secondary murine lymphoid organs: assessment by a PCR assay with extrachromosomal plasmids. (1991) (9)
- Differential cell division history between neutrophils and macrophages in their development from granulocyte–macrophage progenitors (2006) (9)
- Diversity of Cellular Molecules in Human Cells Detected by Monoclonal Antibodies Reactive with c‐myc Proteins Produced in Escherichia coli (1989) (9)
- Preclinical safety pharmacology study of a novel protein-based cancer vaccine CHP-NY-ESO-1. (2008) (9)
- Effects of atorvastatin on serum lipids, lipoproteins, and hemostasis (2005) (9)
- Effector cells of lethal graft-versus-host disease (GVHD) in nude mice. (1989) (9)
- The role of CD8+ and CD4+ cells in rejection of multiple minor H-disparate skin grafts. (1989) (9)
- Possible involvement of calcineurin in retinoic acid-induced inhibition of leukemic HL-60 cell proliferation. (1998) (9)
- State-of-the-Art Review : Outcome of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in Japan (1999) (9)
- Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine. (2003) (8)
- Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells. (2004) (8)
- Adoptive Transfer of WT1-Specific TCR Gene-Transduced Lymphocytes in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia (2015) (8)
- Production and characterization of monoclonal antibodies against the polyamine, spermine: immunocytochemical localization in rat tissues (1994) (8)
- Site restricted and neuron dominant expression of α2,8sialyltansferase gene in the adult mouse brain and retina (1996) (8)
- Mouse. I. Murine leukemia virus-related antigens and allo- antigens on cultured fibroblasts and sarcoma cells. Description of a unique antigen on balb/c meth a sarcoma. (1977) (8)
- Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma (2003) (8)
- Plasma Levels of Heparin Cofactor II (HCII) and Thrombin-HCII Complex in Patients with Disseminated Intravascular Coagulation (2002) (8)
- Role for C-MPL and its ligand thrombopoietin in early hematopoiesis. (1997) (8)
- Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum. (1999) (8)
- Bcl-2 in Cell-Cycle Regulation of Hematopoietic Cells by Transforming Growth Factor-β1 (2000) (8)
- Phase I and preliminary phase II studies on aclacinomycin A in patients with acute leukemia (1980) (8)
- Limited expression of cancer-testis antigens in renal cell carcinoma patients. (2013) (8)
- Fluorescent In Situ Hybridization Analysis of Philadelphia Chromosome-Negative Chronic Myeloid Leukemia with the bcr/abl Fusion Gene (2004) (8)
- Whole-bladder irradiation and doxorubicin-containing chemotherapy as successful treatment for a primary mucosa-associated lymphoid tissue lymphoma of the bladder. (2000) (8)
- Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells. (1995) (8)
- Establishment of animal models to analyze the kinetics and distribution of human tumor antigen-specific CD8⁺ T cells. (2013) (8)
- Antigen-receptor gene-modified T cells for treatment of glioma. (2012) (8)
- Stimulation through very late antigen‐4 and ‐5 improves the multifunctionality and memory formation of CD8+ T cells (2014) (8)
- Successful treatment of lymphoid follicular proctitis with sulfasalazine suppositories (2000) (7)
- Identification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensors (2017) (7)
- NY‐ESO‐1 protein glycosylated by yeast induces enhanced immune responses (2010) (7)
- Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas. (2004) (7)
- IL-4 and IL-10 synergistically inhibit survival of human blood monocytes supported by GM-CSF. (2005) (7)
- Immunogenetic identification of functional T-cell subsets. (1976) (7)
- Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. (1999) (7)
- Molecular analysis of PDGFRα/β genes in core binding factor leukemia with eosinophilia (2006) (7)
- Prognostic Impact of Aortic Calcification Index and Ankle-Arm Blood Pressure Indexin Patients under Hemodialysis (2005) (7)
- Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers (2018) (7)
- Up-regulation of small GTP-binding proteins smg P21A and ras P21S during TPA-induced differentiation of human leukemia cell lines. (1993) (7)
- Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury (2014) (7)
- A human T lymphotropic virus type I (HTLV‐I) long terminal repeat‐directed antisense c‐myc construct with an Epstein‐Barr virus replicon vector inhibits cell growth in a HTLV‐I‐transformed human T cell line (1993) (7)
- Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs. (2005) (7)
- State-of-the-Art Review : Coagulation Tests and Anti-Phospholipid Antibodies in Patients Positive for Lupus Anticoagulant (2000) (7)
- Preferential usage of JH2 in D-J joinings with DQ52 in murine lymphocytes. (1989) (7)
- 2015 Guidance on cancer immunotherapy development in early‐phase clinical studies (2015) (7)
- Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation (2017) (6)
- Increased plasma levels of tissue factor pathway inhibitor‐activated factor X complex in patients with disseminated intravascular coagulation (2000) (6)
- Rat primary T cells expressing HTLV‐I tax gene transduced by a retroviral vector: In vitro and in vivo characterization (1996) (6)
- Autoantibodies to c-myc nuclear protein products in autoimmune disease. (1990) (6)
- Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 × anti-c-ErbB-2 bispecific antibody (1999) (6)
- Monoclonal antibodies reactive to human platelets: analysis of their specificities, detected antigen molecules, and their effects on platelet function. (1987) (6)
- [Targeting cancer antigen (MAGE-A4, NY-ESO -1) for immunotherapy]. (2012) (6)
- GD2 Ganglioside‐Specific Monoclonal Antibody Reacts with Murine Cytotoxic T Lymphocytes Reactive with FBL‐3N Erythroleukaemia (1994) (6)
- Selective inhibition of human T-lymphotropic virus type I-transformed human T-cell growth by a tax-targeted conditionally cytotoxic recombinant retrovirus (1994) (6)
- Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer. (2019) (6)
- Purification and partial amino acid sequence of human platelet membrane glycoproteins IIb and IIIa. (1987) (6)
- Autologous and allogeneic typing of human leukemia cells: definition of surface antigens restricted to lymphocytic leukemia cells. (1983) (6)
- Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance. (2022) (6)
- Plasma Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Disseminated Intravascular Coagulation (DIC). (2002) (6)
- Increased Plasma Soluble-adhesion Molecules in Thrombotic Thrombocytopenic Purpura and Disseminated Intravascular Coagulation (1998) (5)
- Changes of Hemostatic Molecular Markers After Gynecological Surgery (2000) (5)
- In vivo Retrovirus‐mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model (1997) (5)
- Endosonographic images of low-grade lymphoma of mucosa-associated lymphoid tissue after radiotherapy. (2001) (5)
- Immunotherapy with Chimeric Antigen Receptor Targeting Intracellular WT1 Gene Product Complexed with HLA-a*24:02 Molecule (2015) (5)
- Production and analysis of HH 10 monoclonal antibodies reactive to immature hematopoietic cells and their use for monitoring acute leukemia cells. (1985) (5)
- Semiquantitative immunoblot analysis of nm23‐H1 and ‐H2 isoforms in adenocarcinomas of the lung: Prognostic significance (2000) (5)
- Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22). (1998) (5)
- Effective Transfer of Membrane Proteins from Intact Cells to Liposomes and Preparation of Liposomal Vaccines (1990) (5)
- A Heparin-coated Circuit Maintains Platelet Aggregability in Response to Shear Stress in an In Vitro Model of Cardiopulmonary Bypass (1998) (5)
- A Case of Acute Myeloid Leukemia with t(7;11)(p15;p15) Mimicking Myeloid Crisis of Chronic Myelogenous Leukemia (2002) (5)
- Transcription effect of nm23-M2/NDP kinase on c-myc oncogene. (1997) (5)
- Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status. (2018) (5)
- A phase II study of (2″ R)-4′ -0-tetrahydropyranyladriamycin (THP) in hematological malignancies (2004) (5)
- Isolation of an IgH gene circular DNA clone from human bone marrow. (1989) (4)
- Nature of focal lesion and location of skin stimulus influence pattern and distribution of somatosensory evoked potentials (SEP): Forensic and clinical uses (1979) (4)
- Differential effects of a murine monoclonal antibody reactive with the disialylgalactosyl residue on the growth of melanoma cells and T cell activation. (1996) (4)
- Frequent p53 mutations on exons-5 and exon-8 in human primary gastric-cancer. (1993) (4)
- [Plasma D-dimer levels in patients with deep vein thrombosis]. (1999) (4)
- Tumor-specific antigens. (1980) (4)
- Clinical significance of low protein phosphatase-1 activity of blasts in acute myelogenous leukemia with high white cell counts. (2001) (4)
- Blocking of cytotoxic T-cell function of MOLF/Ei mice by anti-Ly 35.1 monoclonal antibody. (1989) (4)
- Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia. (2000) (4)
- Redirected CD4+ T Cells Using WT1-Specific T-Cell Receptor Gene Transfer Can Supply Multifactorial Help to Enhance the Anti-Leukemia Reactivity Mediated by Similarly Redirected CD8+ T Cells Using the Identical Gene Transfer (2011) (4)
- Effect of direct infusion of antifungal agent on invasive pulmonary aspergillosis in a patient with acute leukemia (2002) (4)
- G-CSF accelerates the cell-cycling of hematopoietic progenitor cells and abrogates the deceleration by TNF alpha. (1996) (4)
- A possible change in doubling time of haemopoietic progenitor cells with stem cell development (1996) (4)
- Endoscopic resection of coexisting superficial carcinoma and a retention cyst. (2000) (4)
- Immunohistochemical and Semiquantitative Immunoblot Analyses of Nm23-H1 and H2 Isoforms in Normal Human Tissues (1998) (4)
- Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia. (2001) (4)
- EXPERIMENTAL MODELS AND THE ROLE OF RNA IN IMMUNOTHERAPY OF LEUKEMIA (1973) (4)
- A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumour responses in synovial sarcoma patients (2019) (4)
- Haunting appearance of bcr/abl fusion gene products in a patient with therapy related leukaemia. (2006) (4)
- Soluble protein encoded by CD44 variant exons 8–10 in the serum of patients with colorectal cancer (1997) (3)
- Proliferative response of cloned CTL line 10B-5 upon stimulation with soluble clonotypic monoclonal antibody and its blocking by anti-Lyt-2 antibody. (1989) (3)
- Anti B and T cell activity of antiserum to spleen cells of athymic (nu/nu) mice: evidence for surface antigenic differences between functionally distinct subclasses of T and B lymphocytes. (1976) (3)
- Increased hemostatic molecular markers in patients undergoing anticoagulant therapy. (2000) (3)
- Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia. (2000) (3)
- CD19-Negative Diffuse Large B-Cell Lymphoma Shows High Serum LDH Level and Poor Prognosis. (2005) (3)
- A case of T-lineage lymphoblastic lymphoma/leukemia with t(4;11)(q21;p15) that switched to myelomonocytic leukemia at relapse. (1999) (3)
- Stage-specific cell-cycling of hematopoietic progenitor cells. (1997) (3)
- Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes (2015) (3)
- [Acute myelogenous leukemia (M4) occurring during chronic lymphocytic leukemia]. (1997) (3)
- [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma]. (2005) (3)
- Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19. (1997) (3)
- Monoclonal Antibodies against Japanese Encephalitis Virus Envelope Glycoprotein V3 (E) (1988) (2)
- Production of a truncated human c‐myc protein which binds to DNA (1988) (2)
- Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination. (2018) (2)
- Distinctive actions of interleukin-13 and interleukin-4 on growth of hematopoietic progenitors. (1999) (2)
- Manipulation of human early T lymphopoiesis by coculture on human bone marrow stromal cells: potential utility for adoptive immunotherapy. (2013) (2)
- Distinct Characteristics of t(8;21) Acute Myeloid Leukemia with Active KIT Mutation. (2005) (2)
- Randomized phase II clinical trial of NY-ESO-1 protein vaccine combined with cholesteryl pullulan (CHP-NY-ESO-1) in resected esophageal cancer patients (2019) (2)
- Effect of Accessory Cells on Stimulation of Murine T‐Cell Leukemia with Antibodies to the CD3/T Cell Antigen Receptor Complex (1993) (2)
- Myelodysplastic syndrome of del 20q with plasma cell dysplasia. (2011) (2)
- Phase I/II clinical trial of NY-ESO-1-specific TCR-engineered T-cell transfer combined with a novel T-cell stimulator CHP:NE1 for patients with refractory soft tissue sarcoma. (2019) (2)
- Selective inhibition of human T-lymphotropic virus type I-transformed human T-cell growth by a tax-targeted conditionally cytotoxic recombinant retrovirus. (1994) (2)
- Phase 1 Clinical Trial of Adoptive Immunotherapy for Acute Myelogenous Leukemia and Myelodysplastic Syndrome, Using Gene-Modified Autologous Lymphocytes Expressing WT1-Specific T-Cell Receptor (2016) (2)
- High establishment efficiency of lymph node stromal cells which spontaneously produce multiple cytokines derived from adult T-cell leukemia/lymphoma patients. (1996) (2)
- Co-Administration Of Gene-Modified CD4+ T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia (2013) (2)
- Shear stress-induced myosin association with cytoskeleton and phosphorylation in human platelets. (1997) (2)
- [Expression of nm23/NDP kinase and cancer metastasis]. (1996) (2)
- Up-regulation of nm23/NDP kinase expression in regenerating hepatocytes. (1997) (2)
- Successful treatment of lymphoid follicular proctitis with sulfasalazine suppositories. (2000) (2)
- Relationship between T cell receptor clonotype and PD‐1 expression of tumor‐infiltrating lymphocytes in colorectal cancer (2019) (2)
- Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells (2021) (2)
- Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction. (2002) (2)
- Frequent expression of MDR1 and MDR3 genes in acute myelocytic leukemia cells with t(8;21) (q22;q22). (1997) (2)
- Diverse expression of beta 1,4-N-acetylgalactosaminyltransferase gene in the adult mouse brain. (1995) (2)
- Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells (2018) (2)
- Inhibition of telomerase activity correlates with a decrease in the RNA component of telomerase during differentiation. (1997) (2)
- Successful treatment of aplastic anemia with G-CSF and high dose erythropoietin. (1998) (2)
- Possible involvement of protein phosphatase type 2A in tumor necrosis factor alpha-induced tissue factor expression in endothelial cells. (1997) (1)
- lcw , 25-Dihydroxyvitamin D ,-Induced Upregulation of Calcineurin During Leukemic HL-60 Cell Differentiation (2002) (1)
- Gene Expression Profiling of Diffuse Large B-Cell Lymphomas Supervised by CD21 Expression. (2006) (1)
- [Human monoclonal antibodies with human-mouse hybridomas]. (1983) (1)
- Study on hemostasis abnormality in patients with diabetic and nondiabetic chronic renal failure on maintenance hemodialysis (2001) (1)
- [Cancer vaccine immunotherapy]. (2011) (1)
- Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression (2014) (1)
- Production and characterization of monoclonal antibody against 10S DNA polymerase alpha from calf thymus. (1982) (1)
- Cellular and humoral immune responses in patients vaccinated with HER2 protein combined with a novel nanoparticle antigen delivery system of cholesteryl hydrophobized polysacharide(CHP-HER2) (2005) (1)
- Micropatterning with different cell types by dielectrophoretic manipulation (2007) (1)
- Variable region gene analysis of 2 human monoclonal-antibodies to gd3. (1993) (1)
- Surface phenotype of nonadherent peritoneal cells effecting cell-mediated cytotoxicity in vitro for allogeneic and syngeneic murine sarcoma cells. (1976) (1)
- Tumor-Specific TCR-Engineered Donor Lymphocyte Infusion Therapy with Reduced GvHD Induction Utilizing Novel Retrovirus Vector Silencing Endogenous TCR Expression (2014) (1)
- [The role of CD44 adhesion molecules]. (1995) (1)
- HTLV‐1 unrelated adult T‐cell leukemia/lymphoma with unique phenotype and karyotype (2000) (1)
- [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy]. (2012) (1)
- Consensus Report, 1987 (1987) (1)
- [Cancer treatment with gene-modified T cells or DNA vaccine]. (2010) (1)
- [Nuclear P53 immunoreactivity associated with poor prognosis of gastric cancer: preliminary report]. (1992) (1)
- Expression of smg p21A and ras p21 in epidermal neoplasms (2004) (1)
- Elimination of CD4+ T cells may overcome suppression of anti-HER2 immune responses in tumor-bearing hosts. (2003) (1)
- Development of INSOL‐tag for proteome‐wide protein handling and its application in protein array analysis (2019) (1)
- Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity. (2012) (1)
- De Novo CD5+ Diffuse Large B-Cell Lymphoma: Result of a Detail Morphologic Evaluation and Long-Term Follow Up of 128 Patients. (2007) (1)
- Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial (2022) (1)
- [Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma]. (2003) (1)
- Alterations of p53 and k-ras genes in human colorectal-cancer with ulcerative-colitis. (1995) (1)
- First-in-human phase I clinical trial of NY-ESO-1 protein cancer vaccine with a novel adjuvant MIS416, NOD2 and TLR9 stimulant, for patients with NY-ESO-1 expressing solid tumors. (2018) (1)
- 193. Efficacy and Safety of Immunotherapy with Chimeric Antigen Receptor Targeting WT1 and HLA-A24:02 pMHC Complex (2016) (1)
- Aggressive neoplastic plasma cell growth with MLL gene rearrangement after high-dose therapy with autologous stem cell support for multiple myeloma (2001) (1)
- [Successful treatment of invasive pulmonary aspergillosis with G-CSF and M-CSF during long-term bone marrow suppression in hypoplastic leukemia]. (2002) (1)
- EBAG9-silencing exerts an immune checkpoint function without aggravating adverse effects. (2022) (1)
- Molecular Analysis of PDGFRα/β Genes in Core Binding Factor Leukemia with Eosinophilia. (2005) (1)
- Comparison of the Responses of Global Tests of Coagulation with Molecular Markers of Neutrophil, Endothelial, and Hemostatic System Perturbation in the Baboon Model of E. coli Sepsis (2001) (1)
- The role of metabolism on regulatory T cell development and its impact in tumor and transplantation immunity (2022) (1)
- HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma (2022) (1)
- LIPOPROTEIN(A) AND EFFECTIVE RENAL PLASMA FLOW RATE IN OLDER PATIENTS WITH ARTERIOSCLEROTIC DISEASES (1995) (1)
- A Simple Technique to Determine Thrombopoiesis in Thrombocytopenic Patients Using Immature Platelet Fraction (IPF). (2004) (1)
- T Cells + in CD8 Growth Associated with Apoptosis Induction Peptide Vaccine Induces Enhanced Tumor (2010) (1)
- Tumor- and Immune Cell-Derived Exosomes (2014) (1)
- Cell surface antigens: invaluable landmarks reflecting the nature of cells. (2012) (1)
- CD22 expression in acute myeloid leukemia: close correlation with interleukin-2 receptor α-chain (CD25) expression and poor prognosis (2022) (1)
- Immunoscintigraphy of human tumors transplanted in nude mice with radiolabeled anti-ras p21 monoclonal antibodies. (1990) (1)
- PD32-05 PHASE I CLINICAL STUDY ON THE COMBINATION THERAPY OF CHP-NY-ESO-1 CANCER VACCINE AND MIS416 FOR THE TREATMENT OF PATIENTS WITH NY-ESO-1 EXPRESSING REFRACTORY UROTHELIAL CANCER OR CASTRATION-RESISTANT PROSTATE CANCER (2016) (1)
- Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination (2018) (1)
- Cell Surface Antigens on Human Leucocytes Defined by Murine Monoclonal Antibodies (1984) (1)
- Production of monoclonal antibodies reactive with c-myc protein and analysis of the c-myc expression in leukemic cells. (1988) (1)
- Preparation of a murine cell line which stably expresses human T lymphotropic virus type I (HTLV-I) env genome products. (1995) (1)
- Dendritic cells transfected with a polyepitope DNA construct stimulate an antitumor cytotoxic response in various tumors. (2022) (1)
- [Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]. (1984) (0)
- [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy]. (1996) (0)
- A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy (2016) (0)
- Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients (2013) (0)
- [Follicular lymphoma, medium-sized cell type and mixed type]. (1998) (0)
- isoforms Adult acute myeloid leukemia cells do not express nonfunctional Ikaros (2012) (0)
- CTL-based immunotherapy (PP-109) (2010) (0)
- Abstract CT212: Adoptive transfer of wild-type TCR gene transduced T lymphocytes targeting MAGE-A4 antigen to patients with refractory esophageal cancer (2014) (0)
- WS-093 a Tumor immunity and immunosurveillance 1 (2010) (0)
- Human Telomerase Reverse Transcriptase–specific T-Cell Receptor Gene Transfer Redirects T Cells to Display an Effective Antitumor Reactivity Against Adult T-Cell Leukemia (2012) (0)
- Differential Enhancement of Graft-Versus-Host (GVH) and Graft-Versus-Leukemia (GVL) Reactions by Interleukin-12 (IL-12) (1999) (0)
- Regulatory T cells in anti-tumor immune responses (2003) (0)
- GD 2 ganglioside on human T-lymphotropic virus type I-infected T cells : Possible activation of , B-1 , 4N-acetylgalactosaminyltransferase gene by p 4 OtaX ( adult T-cell leukemia / trans-actvatlon / glycosyltransferase ) (2005) (0)
- P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen (2014) (0)
- Purification and Partial Amino Acid Sequence of Human Platelet Membrane Glycoproteins tIb and lila (2005) (0)
- Tumor-Specific Donor Lymphocyte Infusion for Tumor Relapse after MHC-Haploidentical Hematopoietic Stem Cell Transplantation (2016) (0)
- Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting (2017) (0)
- Symposium on progress in diagnosis using immunochemical and molecular biological techniques in internal medicine. Cancer diagnosis by oncogenes. (1990) (0)
- Subpopulations of cytotoxic t cells with different surface phenotypes. Abstr. (1975) (0)
- A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma (2023) (0)
- T-cell lymphoma Δ γ Gene expression profiling of peripheral T-cell lymphoma including (2013) (0)
- Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro (2022) (0)
- Synergistic Interaction between Notch ligand Delta-1 and IL-6/Soluble IL-6 Receptor Fusion Protein in the Generation of BFU-E from Primitive Hematopoietic Progenitors. (2004) (0)
- Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications (Small Methods 2/2022) (2022) (0)
- Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo (2014) (0)
- Modern T cell technologies for immunotherapy of solid tumors (2023) (0)
- Abstract B11: Control of in vivo spatiotemporal dynamics of antigen and adjuvant by a delivery system CHP nanogel markedly improves the immunogenicity and antitumor efficacy of long peptide cancer vaccine. (2013) (0)
- [Molecular biology and multifunctional aspects of nm23/NDPK]. (1998) (0)
- A clinical trial of combined immunotherapy with MAGE-A4 peptide and cultured T lymphocyte for patients with head and neck squamous cell carcinoma (2011) (0)
- Tumor immunity and immunosurveillance, session 2 (WS-093b) Chairpersons: Takashi Nishimura, Jean-Pierre Abastado (2010) (0)
- Divergent Roles of Histone Deacetylases in Human Adult Eythropoiesis. (2005) (0)
- 121 Tetraspanin molecule CD9 as a novel marker of tumor-reactive T cells (2022) (0)
- and argatroban during in vitro extracorporeal circulation Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist (2013) (0)
- Polyvalent Cancer Vaccine with a Novel Antigen Delivery System, CHP (cholesterol bearing polysaccharides) (2010) (0)
- Search for Cancer Antigens ; Monoclonal Antibodies and Oncogenes (1989) (0)
- The influence of different donor rat strains on the immune response in a mouse recipient. (1999) (0)
- Therapeutically Infused Redirected T Cells Targeting WT1 Successfully Inhibited Leukemia Stem Cells in Vivo (2012) (0)
- [Allogeneic bone marrow transplantation in 14 cases of leukemia]. (1982) (0)
- Molecular and Phenotypic Analysis of Philadelphia Chromosome-Positive Bilineage Leukemia: Possibility of a Lineage Switch from T-Lymphoid Leukemia Progenitor to Myeloid Cells Via PU.1 Expression. (2005) (0)
- IMMU-08. NOVEL NANOPARTICLE-BASED DELIVERY OF H3.3K27M PEPTIDE TO TUMOR-ASSOCIATED MACROPHAGES ENHANCES THE TUMOR HOMING OF H3.3K27M-TCR TRANSDUCED T-CELLS IN HLA-A2/DR1 TRANSGENIC MICE WITH H3.3K27M+ (2021) (0)
- Dual Engineering of Human CD8+ T-Cells with WT1-Specific TCR Gene and Chemokine Receptor Gene Transfer Confers Functionally Strengthened Anti-Cancer Reactivity (2010) (0)
- P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer (2014) (0)
- Analysis of lymphocyte differentiation antigens with hybridoma monoclonal antibodies. (1981) (0)
- Differential Requirement for Cell Division in the Development of Terminally Differentiated Neutrophils and Macrophages from Their Common Progenitors. (2005) (0)
- Targeting Aurora Kinase with a Superior T-Cell Receptor Gene-Transfer Vector (2015) (0)
- [Diffuse large B-cell lymphoma of the knee occurring 70 years after tuberculous arthritis]. (2004) (0)
- Serological and biochemical characterization of surface antigen expressed on human myeloid cells and identification of six distinct antigen systems. (1988) (0)
- 99 Structural optimization of anti-CEA-GITR-CAR to reduce tonic signaling and improve antigen-specific reactivity (2020) (0)
- Irrelevance of the mutated p53 gene product to tumor rejection antigen in 3-methylcholanthrene-induced fibrosarcomas. (1996) (0)
- Early tumor regression following severe lung injury after allogeneic stem cell transplantation in a patient with renal cell carcinoma. (2007) (0)
- Title Guanine-rich sequences are a dominant feature of exosomalmicroRNAs across the mammalian species and cell types (2018) (0)
- Effector mechanism of H-Y and non-H-2 incompatible skin graft rejection in mice. (1989) (0)
- Oligoclonal expansion of cd8+ T-lymphocytes in cultured peripheral lymphocytes derived from asymptomatic HTLV-I carriers. (1994) (0)
- Immunological and Clinical Responses in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL) after RHAMM-R3 Peptide Vaccination. (2007) (0)
- [Application of hemostatic molecular markers for diagnosis of thrombosis]. (2000) (0)
- Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen (2017) (0)
- Forced Expression of CC Chemokine Receptor 2 Enhances Anti-Cancer Reactivity Mediated by T Lymphocytes Beforehand Redirected Toward WT1 Inside the Tumor Microenvironment (2011) (0)
- Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement (2011) (0)
- Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy (2022) (0)
- Adult acute myeloid leukemia cells do not express nonfunctional Ikaros isoforms. (2002) (0)
- Abstract B34: Signal transducing adaptor protein 2 (STAP2) has the crucial role in maintaining the CTL function of memory T cells (2015) (0)
- [Production of monoclonal antibodies]. (1987) (0)
- [Diffuse small lymphocytic lymphoma]. (1998) (0)
- CANCER DEFINED BY AUTOLOGOUS TYPING (1979) (0)
- Oncogenesis and antigenic change of cells: Melanoma and adult T-cell leukemia (1991) (0)
- [Adoptive immunotherapy for cancer with genetically engineered T cells]. (2010) (0)
- Abstract 5325: Inhibition of CD4+CD25+ regulatory T cell suppression to anti-tumor responses by OK-432 (lyophilized Streptococcus pyogenes) (2010) (0)
- [OPINION] Problems of cancer vaccine therapy development (2017) (0)
- Delta-1 Promotes Soluble IL-6R-Mediated Action of IL-6 on Human Erythropoiesis While Counteracting the Effect of IL-6 on the Generation of Myeloid-Lineage Cells. (2005) (0)
- Negative dielectrophoretic manipulation with microparticles for rapid immunosensing (2008) (0)
- Kinase group protooncogenes in non-hodgkins-lymphomas and nonmalignant lymphoid-tissues - analysis of their expression by insitu hybridization assays. (1992) (0)
- Plasma‐activated factor VII level in patients positive for lupus anticoagulant (1997) (0)
- [Progress in the field of hematology in the last 100 years: Immunotherapy]. (2002) (0)
- Association of Circulating CD34+ Cell Count with Liver Conditions. (2004) (0)
- [Two cases of acute non-lymphoblastic leukemia treated with allogeneic bone marrow transplantation]. (1982) (0)
- Brief report Gene expression profiling of peripheral T-cell lymphoma including (cid:1)(cid:2) T-cell lymphoma (2009) (0)
- Abstract 2441: An innovative treatment modality of antibody therapy against intracellular tumor antigens (2010) (0)
- [Current status of cancer management. 4. Possibility for cancer immunotherapy]. (1998) (0)
- Isolation of Human nm 23 Genomes and Analysis of Loss of Heterozygosity in Primary Colorectal Carcinomas Using a Specific Genomic Probe 1 (2006) (0)
- Phase I study of CHP-HER2 polyvalent cancer vaccine, HER2 protein combined with a novel nanoparticle antigen delivery system of cholesteryl hydrophobized polysaccharides (2005) (0)
- Histopathological Study of Alveolar Bone Resorption Induced with Injections of Escherichia coli Endotoxin into Gingiva of T Cell-depleted Mice. (1995) (0)
- Heterogeneity of t cells. Different representations of ly alloan- tigens on killer cells and helper cells. (1975) (0)
- Abstract 4751: Peptide vaccine induces apoptosis of antigen-specific CD8+T cells (2010) (0)
- Abstract 5615: Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model (2010) (0)
- Development of Negative Dielectrophoretic Cellular Patterning System for Living Cells (2006) (0)
- [Changes of ADAMTS13 activity and endothelial cell markers in TMA cases]. (2004) (0)
- Possible Involvement of Histone Acetylation in Differentiation of Erythroid Precursors and Proliferation of Granulocytic Precursors. (2004) (0)
- [Development of immunotherapy against HER2/neu: hydrophobized polysaccharides/oncoprotein complexes and human dendritic cells]. (1999) (0)
- Redirected CD4+ T Cells towards HLA Class I-Restricted WT1 Epitope Successfully Display Multifactorial Helper Function for the Enhancement of Antileukemia Efficacy Mediated by Redirected T-Cell Based Immunocelltherapy. (2012) (0)
- Targets for Passive Immunotherapy Intracellular Tumor-Associated Antigens Represent Effective (2012) (0)
- 19. Leukemia and Lymphoma (1987) (0)
- O3-7-4Analysis of biomarkers in a pilot study of pertuzumab, trastuzumab and eribulin for advanced HER2 positive breast cancer (2016) (0)
- [Clinical evaluation on SM-4300 for severe infections complicated with hematological disorders--a comparative study with cross-over method]. (1984) (0)
- 359 Hyaluronic acid nanogel based cancer vaccine, in combination with adoptive T cell therapy totally suppresses ICI resistant-tumors (2022) (0)
- [Oncogenes and its products in hematopoietic malignancies]. (1987) (0)
- Physicians AbstractsEBMT 2011 (2011) (0)
- [Mantle cell lymphoma]. (1998) (0)
- Increased Membrane Proteinase 3 Expression on Neutrophils in Patients with Infectious Disease. (2004) (0)
- [Immunoassays of cancer markers--production and analysis of monoclonal antibodies reactive with ras oncogene p21]. (1987) (0)
- Augmented Expression of WT1-Specific TCR and Inhibition of Mispaired-TCR Formation In TCR-Gene Modified T-Cells Can Concomitantly Be Achieved Using a Novel Retroviral Vector with Silencers for Endogenous TCRs (2010) (0)
- Human Telomerase Reverse Transcriptase-Specific T-Cell Receptor Gene Transfer Redirects T-Lymphocytes to Exert Effective Antitumor Reactivity Against Adult T-Cell Leukemia, (2011) (0)
- Ebp1 expression is induced by influenza virus infection (2008) (0)
- Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research (2012) (0)
- Development of murine mast cells from primitive hematopoietic progenitor cells supported by cytokines in culture (2000) (0)
- Biochemical and immunologic diagnosis of cancer. Leukemia and lymphoma. (1987) (0)
- MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours (2020) (0)
- Functional Polymer-coated Exosomes : Nanogel Hybrid Assembly for Drug Delivery System (2013) (0)
- Progress of cancer immunotherapy (CS-1) Chairpersons: Nicholas Restifo, Yutaka Kawakami (2010) (0)
- Novel Cellular Immunotherapy Using Allogeneic Vγ9/δ2-T Cells Gene-Modified to Express HTLV-1 P40Tax-Specific TCR for the Treatment of Adult T Cell Leukemia (2019) (0)
- An Indispensable Role of GM-CSF in the Differentiation of Human Blood Monocytes toward Langerhans Cells. (2005) (0)
- Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells (2023) (0)
- Abstract PR02: Antigen delivery targeting tumor-infiltrating macrophages leads to eradication of tumor highly resistant to immune checkpoint inhibitors (2017) (0)
- In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer (2013) (0)
- Molecular Biology of Enzymes Involved in Ganglioside Biosynthesis (1993) (0)
- [Successful treatment of Crow-Fukase syndrome with radiation therapy]. (2002) (0)
- A Role for Notch Signaling in the Commitment of Human Blood Monocytes to Langerhans Cells. (2004) (0)
- [Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation]. (2001) (0)
- Development of Novel Stem Cell Transplantation and Gene-Immunotherapy Using WT1-Specific T-Cell Receptor Gene. (2009) (0)
- [Dot hybridization with synthetic oligonucleotide; analysis of point mutation of c-ras genes]. (1990) (0)
- [Translational research of cancer vaccine]. (2011) (0)
- Effect of in Vivo Administration of Anti-Lyt-2 mAb and Anti-L3T4 mAb on Tumor Rejection (1989) (0)
- Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy (2015) (0)
- 17-1The present state of medical care of cancer patients. 4. Possibility of immunotherapy against cancer. (1998) (0)
- Tumor immunity and immunosurveillance, session 1 (WS-093a) Chairpersons: Kazuyoshi Takeda, Bruce Robinson (2010) (0)
- Airway Inflammation Regulatory T Cells in Th 2-Type + CD 25 + and Preactivated Allergen-Specific CD 4 Differential Regulatory Function of Resting Kuribayashi and Takuma (2008) (0)
- Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1 (2022) (0)
- Abstract 2408: Selective delivery of NY-ESO-1 antigen protein by cholesteryl pullulan (CHP) to CD8α+ dendritic cells in the draining lymph node for cross-presentation (2010) (0)
- Reprogramming of human post-mitotic neutrophils into macrophages by growth factors Running head: Reprogramming of neutrophils into macrophages (2003) (0)
- Biliary Carcinomas Induced in the Hamster (2009) (0)
- [Oncogene products as tumor markers]. (1987) (0)
- Higher frequency of ras oncogene activation in gastric stump carcinomas due to special conditions in the gastric remnant. (1994) (0)
- [Cancer diagnosis by oncogenes]. (1990) (0)
- Engineering of Human T-Cells with a Novel Aurora-A Kinase-Specific T-Cell Receptor Gene Transfer Confers Anti-Leukemia Reactivity (2010) (0)
- AML with t(8;21) and trisomy 4: Possible involvment of c-kit? (multiple letters) [8] (2003) (0)
- Phenotype and effector functions of GD2-specific CAR-T lymphocytes in vitro (2022) (0)
- A stomach oncofetal antigen recognized by monoclonal antibody GC302 (1987) (0)
- growth factors Reprogramming of human post-mitotic neutrophils into macrophages by (2013) (0)
- SS9-4 Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation (2010) (0)
- Development and Function of Exosomes as Bio–nanotransporters (2015) (0)
- Specific Active Immunization Against Cell Surface Antigens of Human Malignant Melanoma: Development of an Approach (1981) (0)
- GVHR Basic and Clinical Aspects (1986) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hiroshi Shiku?
Hiroshi Shiku is affiliated with the following schools: